The advent of cancer genomics has shown that there are far more somatic mutations than hitherto imagined. Although large karyotypic changes have been known for decades, there are a myriad of small rearrangements, whereas the number of mutations can exceed 10^5^ per genome ([@bib15]; [@bib37], [@bib38]; [@bib32]). Apart from cancers involving mutagens that leave genetic signatures, such as aflatoxin or benzo\[*a*\]pyrene, overall there is an excess of CG-\>TA transitions in cancer genomes ([@bib15]). For some genomes there is a pronounced 5′ base context, notably TpC for C-\>T transitions ([@bib31]; [@bib38]; [@bib1]). Of course, the G-\>A transition is merely a C-\>T transition on the opposite strand, suggesting a single transition.

The human APOBEC3 (A3) family of seven genes encoding six functional cytidine deaminases (APOBEC3A, A3B, A3C, A3F, A3G and A3H) has come to the fore in recent years as host cell mutators of viral DNA ([@bib18]; [@bib34]; [@bib16]; [@bib23]; [@bib24]; [@bib25]). They are closely related to activation-induced deaminase (AID), which is responsible for immunoglobulin class switch recombination and somatic hypermutation or rearranged *VDJ* genes ([@bib11]). Indeed, it is thought that the *A3* locus emerged by gene duplication of *AID* ([@bib9]). Like AID, the substrate specificity of the A3 enzymes is the cytidine base in single-stranded DNA (ssDNA), the product being uridine, which base pairs as thymidine. As such, they effectively hypermutate DNA, the mutational load being so great that the viral genetic information is irretrievably lost. That several *A3* genes are upregulated by type I and II interferons lent credence to their being novel restriction factors and part of a broad innate immune response to microbes ([@bib5]; [@bib21]; [@bib33]; [@bib36]). These APOBEC3 mutator enzymes must be tightly controlled as at least four (A3A, A3B, A3C and A3H) can access the nucleus ([@bib45]; [@bib36]; [@bib22]; [@bib39]; [@bib2]; [@bib35]; [@bib6], [@bib7]).

More recently, it has emerged that APOBEC3A (A3A) and probably APOBEC3B (A3B) can mutate nuclear DNA (nuDNA) ([@bib39]; [@bib2]; [@bib35]; [@bib6]). A3A can edit both cytidine and 5-methylcytidine residues in ssDNA ([@bib8]; [@bib48]; [@bib41]) and can generate DNA double-strand breaks ([@bib22]; [@bib30]). Low levels of A3 mutation that do not overwhelm DNA mismatch repair are probably the source of the CG-\>TA mutations in cancer genomes. By contrast, hypermutation is proapoptotic and represents a novel pathway for DNA catabolism ([@bib39]; [@bib30]). Hypermutated nuDNA with hundreds of mutations per kilobase can be found in both pathological and physiological settings ([@bib39]). Invariably the mutations are influenced by the base 5′ with a Tp[C]{.ul} and Cp[C]{.ul} being the preferred targets (the edited cytidine residue being underlined) ([@bib39]; [@bib31]; [@bib1]). Only A3G shows a strong penchant for Cp[C]{.ul} ([@bib3]; [@bib4]; [@bib44]; [@bib17]; [@bib46]). By contrast, AID prefers a purine residue in the 5′ position, where Gp[C]{.ul}\>Ap[C]{.ul} ([@bib9]; [@bib46]). At low levels of nuDNA editing, compatible with DNA repair, these enzymes are probably the source of the C-\>T transitions seen in cancer genomes ([@bib15]; [@bib37], [@bib38]; [@bib32]; [@bib31]). While the relative contribution of A3A and A3B to the editing of nuDNA needs to be ascertained, the *A3B*^*−/−*^ genotype is particularly prevalent in SE Asia ([@bib19]). Interestingly, these individuals have a higher odds ratio of developing breast and liver cancer compared with controls ([@bib20]; [@bib49]).

DNA that has been hypermutated by an APOBEC3 (A3) enzyme can be recovered by a technique called 3DPCR, which stands for differential DNA denaturation PCR ([@bib43]). This method exploits the fact that A3-edited DNA is richer in A+T compared with the reference. Modulation of the PCR denaturation temperature allows selective amplification of AT-rich DNA, sometimes by up to 10^4^-fold ([@bib42]).

While 3DPCR was first used to detect hypermutated viral genomes ([@bib42]; [@bib45], [@bib46]; [@bib40]), it is being increasingly used to recover low levels of A3-edited nuclear DNA. Two recent papers are noteworthy because they used 3DPCR to recover lightly edited DNA sequences manifesting ∼2--13 CG-\>TA transitions per kilobase of nuDNA ([@bib35]; [@bib6]). They exploit the use of 4--5 °C temperature gradients across the 12-wells of the heating block, which is small in comparison with the ±0.4 °C temperature stability per well leaving considerable room for experimental variation. One study presented the sequences in sufficient detail -- the sequences were not monotonously substituted by C-\>T or G-\>A ([@bib35]); rather they contained both mutations on the same strand. Furthermore, a preferred 5′Gp[C]{.ul} editing context was frequently noted, which is more typical of AID rather than an A3 enzyme ([@bib3]). Although ectopic upregulation of AID has indeed been reported ([@bib14]; [@bib26]; [@bib29]), we were concerned that such low-editing rates per kilobase might be close to the 3DPCR error threshold. The second study implicated A3B in nuDNA editing ([@bib6]), yet the signal was only 2--3-fold over 3DPCR background, which we found surprisingly low, particularly as A3B can extensively edit HBV DNA, the editing rates being of the order of \>100  kb^−1^ ([@bib42]; [@bib46]).

Here we explore explicitly 3DPCR error using cloned DNA. It transpires that the 3DPCR error rate is of the order of 4--20 kb^−1^ and generates sequences encoding both C-\>T and G-\>A substitutions occurring preferentially in the Gp[C]{.ul} dinucleotide. Sequences with similar traits have been recovered from human DNA ([@bib35]; [@bib6]).

Materials and methods
=====================

Blood was obtained from anonymous healthy donors and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient (Eurobio AbCys, Courtaboeuf, France). Isolation of CD4^+^ T lymphocytes was performed by incubation with antibody-coated magnetic beads (Miltenyi Biotec, Bergish Glabach, Germany). Purity of CD4^+^ T lymphocytes was above 90% as checked by flow cytometry (FACSCalibur; Becton Dickinson, Franklin Lakes, NJ, USA). CD4^+^ T lymphocytes were stimulated with 10 *μ*g ml^−1^ PHA (Sigma, St Louis, MO, USA), 100 U ml^−1^ IL-2 (Sigma) and 500 U ml^−1^ IFN-*α* (PBL Biomedical Laboratories, Piscataway, NJ, USA) for 48 h. For the detection of hypermutation by 3DPCR, CD4^+^ T cells were transduced with lentivirus rV2.EF1.UGI, which encodes a codon optimised UNG inhibitor (UGI) under the control of the constitutive human EF1 promoter (Vectalys, Toulouse, France).

A molecular clone corresponding to 376 bp spanning exon 8 and intron 9 of the human *TP53* gene was recovered from HeLa cells. For amplification of human *TP53*, input DNA was ∼1 ng. The first-round reaction parameters were 95 °C for 5 min, followed by 40 cycles (95 °C for 30 s, 60 °C for 30 s and 72 °C for 2 min), and finally 10 min at 72 °C with the following primers: P53ext5 (5′-GAGCTGGACCTTAGGCTCCAGAAAGGACAA-3′) and P53ext3 (5′-GCTGGTGTTGTTGGGCAGTGCTAGGAA-3′). Second-round 3DPCR was performed with 1/50 of the first round as input using an Eppendorf Mastercycler ep Gradient S (Eppendorf AG, Hamburg, Germany) programmed to generate a 4 °C gradient in the denaturation temperature. The reaction parameters were 86--90 °C for 5 min, followed by 42 cycles (86--90 °C for 30 s, 58 °C for 30 s and 72 °C for 2 min), and finally 10 min at 72 °C. The buffer conditions were 2.5 m[M]{.smallcaps} MgCl~2~, 16 m[M]{.smallcaps} (NH~4~)~2~SO~4~, 67 m[M]{.smallcaps} Tris-HCl (pH 8.8), 0.01% Tween-20, 200 *μ*[M]{.smallcaps} each deoxynucleoside triphosphate, 100 *μ*[M]{.smallcaps} each primer (P53int5, 5′-TTCTCTTTTCCTATCCTGAGTAGTGGTAA-3′ P53int3, 5′-AAAGGTGATAAAAGTGAATCTGAGGCATAA-3′) and 1.5 U of *Taq* (EurobioTaq+ Eurobio AbCys) or *Pfu* (PfuUltra II Fusion HS DNA Polymerase; Agilent Technologies, Santa Clara, CA, USA) DNA polymerase.

Conditions of amplification of the *β*-catenin were 95 °C for 5 min, followed by 35 cycles (95 °C for 30 s, 60 °C for 30 s and 72 °C for 10 min) and finally 20 min at 72 °C with the following primers: 5′*β*catout (5′-AGCTGATTTGATGGAGTTGGACA-3′) and 3′*β*catout (5′-CCAGCTACTTGTTCTTGAGTGAA-3′). Nested PCR was performed with 1/50 of the first round, conditions were 80--87 °C for 5 min, followed by 35 cycles (80--87 °C for 30 s, 60 °C for 30 s and 72 °C for 10 min) and finally 20 min at 72 °C with the following primers: 5′*β*catin (5′-ACATGGCCATGGAACCAGACAGA-3′) and 3′*β*catin (5′-GTTCTTGAGTGAAGGACTGAGAA-3′).

For long-range PCR, the first-round reaction parameters were 95 °C for 5 min, followed by 40 cycles (95 °C for 30 s, 60 °C for 30 s and 72 °C for 10 min), and finally 20 min at 72 °C. The reaction parameters for the second-round 3DPCR were 86--90 °C for 5 min, followed by 42 cycles (86--90 °C for 30 s, 58 °C for 30 s and 72 °C for 10 min), and finally 20 min at 72 °C. The buffer conditions were 2.5 m[M]{.smallcaps} MgCl~2~, 1 × LA PCR Buffer ll (TaKaRa LA *Taq*; TaKaRa, Otsu, Japan), 400 *μ*[M]{.smallcaps} each deoxynucleoside triphosphate (TaKaRa LA *Taq*; TaKaRa), 100 *μ*[M]{.smallcaps} each primer and 1.5 U of *Taq* (EurobioTaq+ Eurobio AbCys).

Results and discussion
======================

We tested the 3DPCR error rate using the first PCR amplification corresponding to 235 bp. For a 4 °C gradient across the block, the temperature of the last positive amplification varied by 0.9 °C from 89.6 °C for the outer rows A and H to 88.7 °C for the inner rows D and E ([Figure 1A](#fig1){ref-type="fig"}), showing that small thermal gradients are not strictly uniform across the block. Two 3DPCR-positive samples identified by asterisks were cloned and sequenced, and the majority (70--80%) of sequences carried both C-\>T and G-\>A transitions with up to 5 per clone, with an average of 7.5 kb^−1^ for sample D8 (88.7 °C) compared with the input sequence ([Figure 1B and C](#fig1){ref-type="fig"}), the most divergent being shown in [Figure 1D](#fig1){ref-type="fig"}. For A10 (89.6 °C) the overall mutation rate was similar (7.4 kb^−1^; [Figure 1B](#fig1){ref-type="fig"}). While transversions accounted for ∼8% of the total, there was an excess in favour of N-\>A,T. Such observations are to be expected for a technique that selectively amplifies AT-rich DNA and contrasts strongly with the mutation bias of *Taq* polymerase, which generates more A-\>G and T-\>C transitions than any others ([@bib12]).

Most sequences contained both C-\>T and G-\>A substitutions, although there were a few with just one type of transition ([Figure 1D](#fig1){ref-type="fig"}; the issue of PCR recombination ([@bib27]) is addressed below). Interestingly the 5′ dinucleotide context for these 3DPCR mutations is Gp[C]{.ul} for both types of transition ([Figure 1E](#fig1){ref-type="fig"}). There was a weaker 3′ context that tends to [C]{.ul}p*R*, where *R*=G or A ([Supplementary Figure 1A](#sup1){ref-type="supplementary-material"}). As the 5′ and 3′ contexts are the same for both G-\>A and C-\>T transitions, this suggests that a single mutation is involved occurring in the motif 5′Gp[C]{.ul}pR.

Abasic DNA sites can result from slightly acidic conditions and can be copied by inserting an A. This is one of the reasons why long-range PCR buffers showing low p*K*a variation with temperature are used, unlike the standard Tris-HCl buffer ([@bib13]). Accordingly, we repeated the above experiment using long-range buffer, but using the same *Taq* enzyme as before. For a 4 °C variation there was spatial variation across the heating block, with 3DPCR positivity varying by an apparent 1.7 °C ([Figure 2A](#fig2){ref-type="fig"}). Qualitatively the sequences with both G-\>A and C-\>T transitions ([Figure 2B](#fig2){ref-type="fig"}) were identified while the same preference for 5′GpC was observed ([Figure 2C and D](#fig2){ref-type="fig"}) and a weaker 3′ bias for [C]{.ul}pR ([Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). Interestingly, the overall mutation frequency was approximately two-fold higher (4--20 kb^−1^) than for the experiment using standard *Taq* buffer ([Figure 2B](#fig2){ref-type="fig"} *vs* [Figure 1B](#fig1){ref-type="fig"}). When *Pfu* polymerase was used instead of *Taq* comparable results (mixed sequences, a Gp[C]{.ul} context bias, mutation frequencies ∼13 kb^−1^) were obtained including the same Gp[C]{.ul} bias ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}).

Given these experimental baselines using cloned DNA, we turned to DNA from peritumoral cirrhotic tissue from patients with HBV- or HCV-associated hepatocellular carcinoma (HCC). We had previously shown that numerous *A3* genes were upregulated in the liver ([@bib46]). As the *β-catenin* gene, *CTNNB1*, harbors mutations in residues 32--45 in approximately 10--40% of HCCs ([@bib28]; [@bib10]), we focused on a 155 bp segment that encodes this region. Three cirrhotic samples (nos. 310, 326 and 345) were analyzed along with tissue from one healthy liver (HL2). Sample nos. 310 and 345 harboured *CTNNB1* mutations in the accompanying tumour, whereas no. 326 did not. Differential DNA denaturation PCR was performed using a 7 °C denaturation gradient (80--87 °C) and *Taq* polymerase. DNA from the last positive amplification was cloned and sequenced.

Once again sequences with both C-\>T and G-\>A substitutions dominated with up to four such substitutions per sequence, although there were a few sequences encoding just one type of transition ([Figure 3A and B](#fig3){ref-type="fig"}). The overall mutation frequency for sample no. 310 was ∼3 × that for sample nos. 326, 345 and HL2 and more than 13 x the plasmid control ([Figure 3C](#fig3){ref-type="fig"}). Once again the GpC context predominated ([Figure 3D](#fig3){ref-type="fig"}), which argues against the involvement of an A3 enzyme.

Is it possible to distinguish lightly A3-edited sequences from the 3DPCR background described above, and what would an unambiguous A3-edited *β*-catenin look like? As haematopoietic cells generally show high *A3* expression levels compared with other tissues (<http://www.biogps.org>), we analysed DNA from purified CD4^+^ T cells from PBMCs that had been treated by PHA, IL-2 and interferon-*α*, which strongly upregulates the *A3A* gene ([@bib2]). To increase detection of A3-edited nuDNA, the cells were transduced with a lentivirus encoding the uracil *N*-glycosylase inhibitor UGI to block catabolism of dU-containing DNA ([@bib47]). Using a 7 °C gradient 3DPCR amplification of the same *β-catenin* gene segment revealed a signal differing by 1 °C with respect to the non-stimulated CD4^+^ T cells as a control ([Figure 4A and C](#fig4){ref-type="fig"}). Cloning and sequencing revealed monotonously C-\>T or G-\>A substituted sequences ([Figure 4A--C](#fig4){ref-type="fig"}) with editing focused on Tp[C]{.ul} ([G]{.ul}pA) dinucleotides, all consistent with editing by A3A and/or A3B ([Figure 4E and F](#fig4){ref-type="fig"}).

The non-stimulated control proved interesting. The last positive 3DPCR amplification was at 83.7 °C in the centre of the block to minimise the effects of thermal heterogeneity ([Figure 4A and B](#fig4){ref-type="fig"}). A collection of sequences was found that could be broken down into two groups of AT-rich sequences ([Figure 4C](#fig4){ref-type="fig"}). The first group of 10 sequences corresponded to what we can call 3DPCR background sequences containing up to five substitutions per locus (32 kb^−1^) involving both C-\>T and G-\>A transitions, there being a bias for transitions in Gp[C]{.ul} dinucleotides (not shown). The second group of two sequences in [Figure 4C](#fig4){ref-type="fig"} were monotonously G-\>A substituted compared with the plus strand with five and six transitions, most of which were in Tp[C]{.ul} and Cp[C]{.ul}. Indeed, the dinucleotide context is very similar to that of the *bona fide* A3-edited *β*-catenin sequences recovered from IFN-*α*-stimulated CD4^+^ T cells ([Figure 4A](#fig4){ref-type="fig"}). Accordingly, it appears that 3DPCR is indeed capable of recovering lightly A3-edited sequences when present.

The constant presence of sequences bearing both C-\>T and G-\>A transitions was intriguing, no matter what the source of input DNA was -- molecularly cloned, and tissue- or PBMC-derived DNA. We have previously shown that recombination during PCR can contribute to the complexity of amplified DNA ([@bib27]). It usually occurs towards the end of amplification when \[DNA\]\>\[Taq\], the polymerase simply being unable to complete synthesis of the nascent strands before the next temperature shift to denaturation.

Long elongation times reduce recombination but do not eliminate the problem ([@bib27]). In the above experiments involving *TP53* and *CTNNB1* loci, 10 min elongation times were used. However, as 3DPCR amplification occurs very close to the denaturation temperature, some templates may not be fully denatured, which would block polymerase elongation, thus rendering amplification less efficient. Indeed, this is reflected by the fact that we regularly use 42 cycles when performing 3DPCR, when normally 30 cycles would be more than sufficient to amplify the TP53 target.

To address the question of PCR recombination, 1 ng of DNA of three different molecularly cloned *CTNNB1* sequences were mixed at an equimolar ratio and 3DPCR performed using the same 7 °C gradient. The last positive amplification (84.7 °C) was cloned and sequenced. By comparison of the input and output sequences ([Figure 4D](#fig4){ref-type="fig"}), it is clear that PCR-mediated recombination can increase the sequence complexity. The most parsimonious explanation for hypermutated sequences bearing both C-\>T and G-\>A transitions is that thermostable polymerases make a spectrum of mutations. For C-\>T and G-\>A transitions, one is dominant and occurs either in the context Gp[C]{.ul}pR (C-\>T transition) or Yp[G]{.ul}pC for a G-\>A transition. Successive cycles of 3DPCR enrich DNA bearing CG-\>TA transitions, and to a lesser extent N-\>TA transversions are selectively amplified. The complexity of the sequences is increased by PCR recombination.

Differential DNA denaturation PCR was initially used to recover A3 edited viral genomes and plasmid DNA ([@bib45], [@bib46]; [@bib39], [@bib40]). Subsequently, it proved crucial to demonstrating that mitochondrial and nuclear DNA could be hyperedited ([@bib39]). Recently two studies have reported A3 editing of nuDNA following recovery by 3DPCR ([@bib35]; [@bib6]). The overall mutation rates were within the 3DPCR error range reported here. For one study the difference in the 3DPCR temperature was never \>1 °C compared to the control while the mutation frequencies were 6--9 kb^−1^, only 2 fold greater than the basal error rate ([@bib35]). Sequences bearing mixed C-\>T and G-\>A substitutions were found while the preferred 5′ dinucleotide context for C-\>T substitutions was Gp[C]{.ul}, observations reminiscent of the data shown in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and suggests that they are non-physiological 3DPCR generated sequences.

If mixed DNA molecules resulted from A3 editing then the first edited strand would have to be replicated, followed by strand separation and APOBEC3 editing. The crucial difference compared to 3DPCR error would be the 5′ dinucleotide context associated with the C-\>T transitions. To date we have only seen sequences with large numbers of both C-\>T and G-\>A transitions in the context of hepatitis B virus editing by A3G ([@bib42]). Here the numbers of C-\>T and G-\>A transitions was much greater than the 3--5 per clone reported here. Furthermore, as the dinucleotide context was 5′Cp[C]{.ul} for the C-\>T transitions on both strands, such sequences can be attributed to A3G editing and not 3DPCR ([@bib42]).

Differential DNA denaturation PCR cannot be used to identify *fixed* C-\>T transitions in cancer genomes. Presently, the overall mutation frequency is ∼10^4^--10^5^ base substitutions per cancer genome, or 0.003--0.03 kb^−1^. These numbers are orders of magnitude lower than those for 3DPCR error, which are of the order of 4--20 mutations per kb; such numbers translate into 12--60 million mutations per diploid genome. As the reported mutation frequencies were of the same order as PCR error, along with mixed sequences associated with the Gp[C]{.ul} context, suggests that in all probability they result from 3DPCR.

Differential DNA denaturation PCR is very powerful at selectively amplifying A3 hyperedited DNA, but as shown above there is a grey zone where the editing frequency falls below 5--15 substitutions per kb^−1^. Having worked with it for many years ([@bib43], [@bib39]; [@bib45], [@bib46]), we would suggest that cloning and sequencing is vital to a correct interpretation of the results. *Prima face* evidence of A3A and A3B editing of nuclear DNA requires that sequences should be monotonously substituted and coupled to a clear preference for Tp[C]{.ul} and Cp[C]{.ul}, the hallmark signature of these enzymes.
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![**Variation in 3DPCR *Taq* polymerase background mutation rate across the PCR block.** (**A**) White spots correspond to PCR-positive samples for a 176 bp fragment of human *TP53*. Those samples indicated by an asterisk were cloned and sequenced. (**B**) Mutation matrices for A10- and D8-derived sequences; transitions were invariably of the type N-\>T,A; the number of bases sequenced is given by n. (**C**) Distribution of the number of CG-\>TA transitions per clone. (**D**) A collection of the most highly mutated sequences. To compact the data, only variable sites are shown, their positions being identified above. Nucleotide positions should be read from top to bottom. To the right are the numbers of mutations per clone (mut) and the minimum number of recombination events (rec) to explain the complexity. Zones of recombination are highlighted in grey shading when possible. (**E**) 5′ Dinucleotide context for the G-\>A and C-\>T transitions, with the expected values shown as horizontal bars.](bjc2014176f1){#fig1}

![**Variation in 3DPCR long-range *Taq* polymerase background mutation rate across the PCR block.** (**A**) White spots correspond to PCR-positive samples for *TP53* DNA. Those samples indicated by an asterisk were cloned and sequenced. (**B**) Mutation matrices for A6-, B3- and C2-derived sequences; transitions were invariably of the type N-\>T,A; the number of bases sequenced is given by n. (**C**) 5′ Dinucleotide context for the G-\>A and C-\>T transitions, with the expected values shown as horizontal bars. (**D**) A collection of the most highly mutated sequences. To compact the data, only variable sites are shown, their positions being identified above. Nucleotide positions should be read from top to bottom. To the right are the numbers of mutations per clone (mut) and the minimum number of recombination events (rec) to explain the complexity. Zones of recombination are highlighted in grey shading when possible.](bjc2014176f2){#fig2}

![**Differential DNA denaturation PCR-derived *CTNNB1* sequences from cirrhotic and normal liver DNA.** (**A**) A collection of 3DPCR recovered *CTNNB1* sequences from viral-associated liver cirrhosis. The amino-acid sequence is shown above where bold case identifies the residues that frequently are substituted in liver cancers. The annotation is as for [Figure 1D](#fig1){ref-type="fig"}. (**B**) Stack-up graph of the number of GC-\>AT transitions per sequence per liver sample. (**C**) Mutation frequencies per sample along with the absolute number of mutations and bases sequences (within parentheses). (**D**) 5′ Dinucleotide context of GC-\>AT transitions for G-\>A and C-\>T transitions respectively.](bjc2014176f3){#fig3}

![**APOBEC3 hypermutated *CTNNB1* sequences from purified human CD4^+^ T cells.** (**A**) A collection of sequences bearing all the hallmarks of APOBEC3 editing from interferon *α* treated purified human CD4^+^ T cells -- monotonously substituted with a penchant for GpA. (**B**) A collection of sequences, this time C-\>T hypermutants from activated human CD4^+^ T cells. (**C**) A collection of sequences recovered from unstimulated CD4^+^ T cells as control for the above. The first group of 10 shows mixed sequences with both C-\>T and G-\>A substitutions, the annotation is as for [Figure 1D](#fig1){ref-type="fig"}. The second group of two sequences is monotonously G-\>A substituted with a penchant for GpA. (**D**) Three different mutated *CTNNB1* molecular clones A, B and C were mixed and amplified by 3DPCR. The lower three sequences are recombinants of the input sequences and denoted as B and C and A and B, the regions of recombination being highlighted in grey. (**E** and **F**) 5′ Dinucleotide context for the G-\>A and C-\>T transitions, with the expected values shown as horizontal bars, NS, unstimulated.](bjc2014176f4){#fig4}
